Infantile onset Vanishing White Matter disease associated with a novel EIF2B5 variant, remarkably long life span, severe epilepsy, and hypopituitarism

April L. Woody*, David T. Hsieh, Harkirtin K. Mciver, Linda P. Thomas, Luis Rohena

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Scopus citations

Abstract

Vanishing White Matter disease (VWM) is an inherited progressive leukoencephalopathy caused by mutations in the genes EIF2B1-5, which encode for the 5 subunits of the eukaryotic initiation factor 2B (eIF2B), a regulator of protein synthesis. VWM typically presents with acute neurological decline following febrile infections or minor head trauma, and subsequent progressive neurological and cognitive regression. There is a varied clinical spectrum of VWM, with earlier onset associated with more severe phenotypes. Brain magnetic resonance imaging is usually diagnostic with diffusely abnormal white matter, progressing over time to cystic degeneration. We are reporting on a patient with infantile onset VWM associated with three heterozygous missense variants in EIF2B5, including a novel missense variant on exon 6 of EIF2B5 (D262N), as well as an interstitial duplication at 7q21.12. In addition, our case is unusual because of a severe epilepsy course, a novel clinical finding of hypopituitarism manifested by hypothyroidism and adrenal insufficiency, and a prolonged life span with current age of survival of 4 years and 11 months.

Original languageEnglish
Pages (from-to)826-830
Number of pages5
JournalAmerican Journal of Medical Genetics, Part A
Volume167
Issue number4
DOIs
StatePublished - 1 Apr 2015
Externally publishedYes

Keywords

  • Adrenal insufficiency
  • Childhood ataxia with central nervous system hypomyelination (CACH)
  • Endocrine dysfunction
  • Epilepsy
  • Eukaryotic initiation factor 2B (eIF2B)
  • Hypopituitarism
  • Hypothyroidism
  • Infantile vanishing white matter (VWM)
  • Leukodystrophy
  • Vanishing white matter (VWM)

Cite this